Skip to main content
. 2022 Apr 21;12:841418. doi: 10.3389/fonc.2022.841418

Figure 5.

Figure 5

Co-expression of GFAP and Iba1 with ACSL4 and GPX4. Given are the numbers of GFAP+ or Iba1+ cells of ACSL4+ or GPX4+ cells. The dots indicate the amounts of each patient in the primary and relapse tumor. (A) The number of GFAP+/ACSL4+ cells decreases insignificantly in the relapse. (B) The amount of Iba1+/ACSL4+ cells significantly decreases in the relapse. (C) The number of GFAP+/GPX4+ cells decreases significantly in the relapse. (D) The amount of Iba1+/GPX4+cells increased significantly in the relapse.